Decker. R. Oldenburg, S. Covalent Bioconjugation of Antibodies To Carboxyl Terminated Nanoparticles
This document describes a method for covalently binding antibodies to carboxyl-terminated nanoparticles through an amide bond. It involves purifying the antibody using a protein A column and removing any amine-containing buffers or stabilizing proteins. The purified antibody is then conjugated to carboxyl-functionalized nanoparticles by forming an amide bond between the primary amine on the antibody and the carboxyl group on the nanoparticle surface. This allows controlling the amount of antibody attached and improves stability compared to physical adsorption. The method is optimized for 40nm gold nanoparticles but can be adapted to other particle types and sizes.
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0 ratings0% found this document useful (0 votes)
70 views1 page
Decker. R. Oldenburg, S. Covalent Bioconjugation of Antibodies To Carboxyl Terminated Nanoparticles
This document describes a method for covalently binding antibodies to carboxyl-terminated nanoparticles through an amide bond. It involves purifying the antibody using a protein A column and removing any amine-containing buffers or stabilizing proteins. The purified antibody is then conjugated to carboxyl-functionalized nanoparticles by forming an amide bond between the primary amine on the antibody and the carboxyl group on the nanoparticle surface. This allows controlling the amount of antibody attached and improves stability compared to physical adsorption. The method is optimized for 40nm gold nanoparticles but can be adapted to other particle types and sizes.
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 1
Optical Imaging 37
Method: Covalent Bioconjugation of
Antibodies to Carboxyl Terminated Nanoparticles Rhea Decker, Steven J. Oldenburg* nanoComposix, Inc 4878 Ronson Ct, San Diego, CA 92111 *Email: [email protected]
Introduction Antibody Purification
Conjugation of antibodies is commonly used as a means of Prior to conjugation, it is critical that the antibody solution does targeting nanoparticles, either for diagnostics or for delivery not contain additional free amines in the storage buffer as it will of nanoparticles to a particular location in vitro or in vivo. compete with binding sites on the nanoparticle. Free amines, In this article, we describe a method for covalently binding including those found in tris buffer or the preservative sodium antibodies through an amide bond to the nanoparticle surface. azide, must be removed and the antibody must be transferred There are many different methods for binding antibodies to a to a suitable amine-free buffer. Likewise, any additional nanoparticle surface. For example, physisorption is a commonly stabilizing proteins in the antibody solution must also be used technique for gold nanoparticles because a clean surface removed. Protein A or other affinity columns can be employed on the gold nanoparticle exhibits a high affinity for the various to isolate the antibody from other proteins. It is to be noted that functional groups present in an antibody. Such binding has been the elution of the antibody from affinity columns often involves used for decades for the preparation of lateral flow diagnostics. the use of amine containing buffers. A subsequent purification However, the physisorption method has several drawbacks. of the antibody into an amine-free buffer is then required. Steps These include: the release of the antibodies off the particles involved in the purification of antibodies are detailed below. over time, difficulty in controlling the amount of antibody on the particles, and the need to optimize the exact conditions for the Materials physisorption with each different antibody. • Millipore Amicon Ultra 0.5 mL 10K filters for protein purification and concentration (Prod. No. Z677108) It has been found that the covalent bonding of antibodies • 2 mL Microcentrifuge tubes (to hold filters) (Prod. No. through an amide bond from a free amine on the antibody to a Z628034) carboxylic acid on the surface of nanoparticles is a simple and reproducible method for creating conjugates and for controlling • Microcentrifuge the amount of antibody on the surface. In addition, in the case • Antibody to be purified of conjugates used in lateral flow diagnostics, substantially less • Purification buffer (e.g., 10 mM potassium phosphate, or antibody is required to generate a functional conjugate. The other amine-free buffer) example method we provide here has been optimized for 40 nm • Bicinchoninic acid (BCA) assay kit (Prod. No. QPBCA) carboxyl functionalized (also known as lipoic acid functionalized) and plate reader or UV/vis spectrophotometer for protein gold nanoparticles. Normalization for the total nanoparticle quantification surface area in solution allows for extension of this chemistry to other sizes of nanoparticles with a carboxyl surface. In addition, Purification Protocol by modifying the centrifugation parameters, the isolation of a 1. Place filter inside microcentrifuge tube. variety of different particles can be achieved. For example, we 2. Add 450 µL of purification buffer and centrifuge 5 minutes at have employed a similar method for carboxyl surfaced materials 13,800 RCF to pre-rinse the filter. including gold nanoshells, gold rods, hollow gold spheres, 3. Dispose of the filtrate at the bottom of the tube. spherical silver nanoparticles (lipoic acid functionalized), silver 4. Aliquot antibody solution into filter and close cap. cubes, silica, quantum dots, and latex beads.
H. R. Bolliger, M. Brenner, H. Gänshirt, Helmut K. Mangold, H. Seiler, Egon Stahl, D. Waldi Auth., Egon Stahl Eds. Thin-Layer Chromatography A Laboratory Handbook